CSL Behring

Innovation Challenge:

Thriving with Transplantation


Select finalists will present their innovative solutions with the potential to improve outcomes and experiences for those affected by transplantation at the virtual summit. One entrepreneur will be awarded the 2021 Lyfebulb-CSL Behring Innovation Award, including a $25,000 monetary grant to grow their company. Applicants must be a Patient Entrepreneur (who have been affected by chronic disease as either a patient or support partner for a loved one and started a company to develop solutions to an unmet need identified in their disease journey). Applications are open through Friday, February 19, 2021, at 11:59 PM EDT.